FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017496708> ?p ?o ?g. }

• W2017496708 abstract "Although the use of bortezomib alone and in combination with steroids has shown efficacy in AL amyloidosis, its role in combination with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) is unknown. In this study, we evaluated bortezomib in combination with dexamethasone (BD) for induction chemotherapy prior to HDM/SCT. This was a single-center, prospective, randomized controlled trial comparing induction therapy consisting of two BD cycles followed by HDM/SCT (BD + HDM/SCT) with HDM/SCT alone in the treatment of patients with newly diagnosed AL amyloidosis. The hematological and organ responses of the patients were assessed every three months post HDM/SCT. Fifty-six patients newly diagnosed with renal (100%), cardiac (57.1%), liver (7.1%), or nervous system (8.9%) AL amyloidosis were enrolled in this study; 28 patients were assigned to each arm. Two patients died within 100 days of HDM/SCT (3.6% treatment-related mortality). The overall hematologic response rates in the BD + HDM/SCT arm and HDM/SCT arm at three, six and twelve months were 78.5% versus 50%, 82.1% versus 53.5% and 85.7% versus 53.5%, respectively. In the BD + HDM/SCT arm, 15 (53.5%) patients achieved a hematologic response after BD and before HDM/SCT. An intention-to-treat analysis revealed a higher rate of complete remission in the BD + HDM/SCT arm at both 12 and 24 months (67.9% and 70%, respectively) than with the HDM/SCT-only therapy (35.7% and 35%, respectively, P = 0.03). After a median follow-up of 28 months, the survival rates at 24 months post-treatment start were 95.0% in the BD + HDM/SCT group and 69.4% in the HDM/SCT alone group (P = 0.03). Our preliminary data suggest that the outcome of treating AL amyloidosis with BD induction and HDM/SCT was superior to the outcome of the HDM/SCT treatment alone. This trial has been registered at clinicaltrials.gov with the number NCT01998503 ." @default.
• W2017496708 created "2016-06-24" @default.
• W2017496708 creator A5008727877 @default.
• W2017496708 creator A5012536776 @default.
• W2017496708 creator A5043017907 @default.
• W2017496708 creator A5048279362 @default.
• W2017496708 creator A5062129651 @default.
• W2017496708 creator A5072312460 @default.
• W2017496708 creator A5075076354 @default.
• W2017496708 creator A5085642649 @default.
• W2017496708 date "2014-01-06" @default.
• W2017496708 modified "2023-10-12" @default.
• W2017496708 title "Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial" @default.
• W2017496708 cites W146910030 @default.
• W2017496708 cites W1903976067 @default.
• W2017496708 cites W1971828262 @default.
• W2017496708 cites W1973423645 @default.
• W2017496708 cites W1998362372 @default.
• W2017496708 cites W1999519330 @default.
• W2017496708 cites W2001594121 @default.
• W2017496708 cites W2024799625 @default.
• W2017496708 cites W2025152462 @default.
• W2017496708 cites W2039150089 @default.
• W2017496708 cites W2039282816 @default.
• W2017496708 cites W2039607042 @default.
• W2017496708 cites W2041167176 @default.
• W2017496708 cites W2042839483 @default.
• W2017496708 cites W2052710970 @default.
• W2017496708 cites W2058789242 @default.
• W2017496708 cites W206392377 @default.
• W2017496708 cites W2069078219 @default.
• W2017496708 cites W2070335603 @default.
• W2017496708 cites W2075174733 @default.
• W2017496708 cites W2076668534 @default.
• W2017496708 cites W2077918440 @default.
• W2017496708 cites W2081723062 @default.
• W2017496708 cites W2089555897 @default.
• W2017496708 cites W2095255742 @default.
• W2017496708 cites W2096207943 @default.
• W2017496708 cites W2098093182 @default.
• W2017496708 cites W2107403553 @default.
• W2017496708 cites W2109651910 @default.
• W2017496708 cites W2111080788 @default.
• W2017496708 cites W2114463958 @default.
• W2017496708 cites W2116664515 @default.
• W2017496708 cites W2124560610 @default.
• W2017496708 cites W2135482314 @default.
• W2017496708 cites W2141145512 @default.
• W2017496708 cites W2147055495 @default.
• W2017496708 cites W2161231801 @default.
• W2017496708 cites W2161648900 @default.
• W2017496708 cites W2169183166 @default.
• W2017496708 cites W2169767242 @default.
• W2017496708 cites W2560500447 @default.
• W2017496708 cites W3174531581 @default.
• W2017496708 cites W3190905615 @default.
• W2017496708 cites W4238487952 @default.
• W2017496708 doi "https://doi.org/10.1186/1741-7015-12-2" @default.
• W2017496708 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3895846" @default.
• W2017496708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24386911" @default.
• W2017496708 hasPublicationYear "2014" @default.
• W2017496708 type Work @default.
• W2017496708 sameAs 2017496708 @default.
• W2017496708 citedByCount "61" @default.
• W2017496708 countsByYear W20174967082014 @default.
• W2017496708 countsByYear W20174967082015 @default.
• W2017496708 countsByYear W20174967082016 @default.
• W2017496708 countsByYear W20174967082017 @default.
• W2017496708 countsByYear W20174967082018 @default.
• W2017496708 countsByYear W20174967082019 @default.
• W2017496708 countsByYear W20174967082020 @default.
• W2017496708 countsByYear W20174967082021 @default.
• W2017496708 countsByYear W20174967082022 @default.
• W2017496708 countsByYear W20174967082023 @default.
• W2017496708 crossrefType "journal-article" @default.
• W2017496708 hasAuthorship W2017496708A5008727877 @default.
• W2017496708 hasAuthorship W2017496708A5012536776 @default.
• W2017496708 hasAuthorship W2017496708A5043017907 @default.
• W2017496708 hasAuthorship W2017496708A5048279362 @default.
• W2017496708 hasAuthorship W2017496708A5062129651 @default.
• W2017496708 hasAuthorship W2017496708A5072312460 @default.
• W2017496708 hasAuthorship W2017496708A5075076354 @default.
• W2017496708 hasAuthorship W2017496708A5085642649 @default.
• W2017496708 hasBestOaLocation W20174967081 @default.
• W2017496708 hasConcept C126322002 @default.
• W2017496708 hasConcept C141071460 @default.
• W2017496708 hasConcept C159654299 @default.
• W2017496708 hasConcept C203014093 @default.
• W2017496708 hasConcept C2776364478 @default.
• W2017496708 hasConcept C2777478702 @default.
• W2017496708 hasConcept C2778684742 @default.
• W2017496708 hasConcept C2779050716 @default.
• W2017496708 hasConcept C2779551797 @default.
• W2017496708 hasConcept C2780401358 @default.
• W2017496708 hasConcept C2911091166 @default.
• W2017496708 hasConcept C36394416 @default.
• W2017496708 hasConcept C71924100 @default.
• W2017496708 hasConcept C90924648 @default.
• W2017496708 hasConceptScore W2017496708C126322002 @default.
• W2017496708 hasConceptScore W2017496708C141071460 @default.

• next